Interactions between prevalent late-life medical conditions and expansion of the cerebral ventricles is not well understood. 30 with age, race, history of heart disease, diabetes, and hypertension as fixed effects. Ventricular acceleration was significantly higher in non-whites, diabetics, and those without heart disease (p¡.05). Ventricular acceleration was higher in subjects with a history of hypertension, but the difference was not statistically significant (p=.08). Acceleration of ventricular expansion in the elderly may be related to demographic and cardiovascular factors.
Introduction
Cross-sectional imaging studies have suggested that the cerebral ventricles expand throughout early adulthood at a steady pace as a result of gradual neuronal death, but that the rate of ventricular expansion accelerates late in life [10] [30] [25] . The question of whether the expansion rate is modulated by risk factors in the elderly could be of clinical importance, since ventricular dilation has been associated with risk of Alzheimer's disease (AD) and with late-life cognitive decline in general [17] [15] . However, since most previous studies measure ventricular volume at one or two time points per subject, they are limited in the information they can provide about the time course of ventricular expansion. For example, if ventricular volume is only measured at two time points in a particular subject, it is not possible to directly measure whether ventricular expansion is accelerating, slowing, or remaining constant over time in that subject. Determining whether comorbidities are associated with fast and steady, as opposed to accelerating, ventricular expansion could be important for understanding the underlying effects of the comorbidities, and for predicting future ventricular volume in a clinical setting.
2
In this study, we measured ventricular volumes at three time points per subject in order to determine whether each subject experienced ventricular expansion that accelerated, slowed, or remained constant over time. Our goal was to determine whether accelerating ventricular expansion was linked to specific clinical factors. Subjects were drawn from a community-based epidemiological study in an attempt to avoid selection bias issues. Following a growing trend in region-of-interest based neuroimaging studies, we computed ventricular volumes using a fully-automated computerized technique to avoid concerns about the reliability and reproducibility of human region-of-interest tracings [9] [36] . We hope that the current study extends the results of an earlier prospective study in which the same image processing methodology was used for prospective analysis of a larger group of subjects who received only a single MR scan at baseline, but returned for a follow-up clinical evaluation 4 years later [6] . 
Methods

Subjects
MRI Acquisition and Processing
MR images were collected from 1997 to 2005 on the same 1.5T Signa scanner (GE Medical Systems) with high performance gradients (4 G/cm and 150 T/m-s). The subjects were positioned in a standard head coil and a volumetric Spoiled Gradient Recalled Acquisition (SPGR) sequence with parameters optimized for maximal contrast among gray matter, white matter, and cerebrospinal fluid was acquired in the coronal plane (TE/TR = 5/25, flip angle = 40 deg., NEX = 1, slice thickness = 1.5mm/0mm interslice). Lateral ventricular volumes were estimated fully automatically on all scans using a technique described in a previous study and validated on a set of dilated ventricles [5] [Carmichael et al. 2006, submitted] . In short, images were resampled to obtain 1x1x1 mm 3 voxels, anisotropically smoothed [33] , skull-stripped [32] , cropped to remove all-zero planes, and geometrically aligned [7] to images on which the lateral ventricles had been delineated manually or automatically. Specifically, 1997-99 images were aligned to a single, randomlyselected subject image on which the lateral ventricles had been manually traced by a trained rater to include the frontal horn and body, as well as the temporal and posterior horns, using a tracing protocol described previously [27] . In the fixed effects analysis, ventricular acceleration is modeled by an overall population mean that is modulated by additive terms that depend on age, race, and presence of heart disease, diabetes, and hypertension. We used the results of the fixed-effects analysis to assess the incremental value of using clinical data Table 1 . Ventricular expansion accelerated in non-whites, diabetics, and those who did not have heart disease. Additionally, higher ventricular acceleration was associated with hypertension, but the difference was not statistically significant. 
Statistical Analysis
Discussion
The key finding of this study is that subjects with hypertension or diabetes experienced ventricular expansion that accelerated over time, independent of age or race. Since hypertension and diabetes are related to higher incidence of MR-identified white matter lesions, and white matter lesions are in turn associated with increased risk of ventricular expansion, we speculate that the accelerating expansion could be related to white matter damage that accumulates continually over time [37] [19] [18] [21] . Diabetes-related structural brain changes may be related to the increased dementia risk among diabetics in the CHS [14] . Future studies involving larger numbers of ventricular volume measurements per subject may help to determine whether ventricular expansion accelerates continually until death, or reaches a steady-state expansion rate, 6 in subjects with hypertension or diabetes.
Acceleration in ventricular expansion was lower in subjects with heart disease. While the relationship between ventricular acceleration and mortality has not been established, we speculate that subjects with a history of heart disease and accelerating ventricular expansion were more likely to excluded from our cohort due to increased mortality associated with ventricular expansion and heart disease. Specifically, a variety of measures related to heart disease were associated with mortality in the CHS [11] , and ventricular expansion was associated with mortality in the CHS and elsewhere [16] [34] . We speculate that concomitant heart disease and quickly accelerating ventricular acceleration increase mortality risk to such an extent that any CHS subjects with these characteristics died before the 2005 follow-up, and were therefore excluded from this study. Among subjects with heart disease, only those with concomitant near-constant ventricular expansion survived to 2005, leading to the appearance of decreased ventricular acceleration among those with heart disease. Low ventricular acceleration could be associated with decreased mortality among subjects with heart disease, for reasons that remain unclear.
Previous studies of the CHS cohort have suggested larger ventricles among non-whites [38] [24] . Since the non-white subjects in this study were African-American, and African-American race has been associated with higher incidence of relatively severe white matter hyperintensities, we speculate that accelerating ventricular expansion among African-Americans could be related to white matter damage that accumulates over time [20] . However, associations between race and brain structure characteristics could also reflect complex interactions between genetics, socioeconomic status, and other factors [13] .
Methodologically, we note that previous studies vary widely with respect to subject selection criteria and accounting for comorbidities. Furthermore, while most studies fit regression lines to plots of ventricular volume as a function of age, our results suggest that linear models of ventricular expansion could possibly be insufficient for accurate modeling, especially among subjects with prevalent late-life comorbidities, and that higher-order models may be more appropriate [25] . In the future, this hypothesis could be tested on a larger data set through statistical tests that directly compare linear and higher-order models, for example those with quadratic terms. Table 2 : Comparison of demographic data between CHS Cognition Study subjects who received 3 clinical evaluations and MRI scans, and the full set of CHS Cognition Study subjects who received at least one clinical evaluation and MRI scan. All data items were measured during the 1997-99 visit. Entries in bold show variables that were significantly different between the groups under 2-sided t tests at the p = .05 level.
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